Staging of non-small-cell lung cancer with integrated PET and CT.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 14503542)

Published in N Engl J Med on September 18, 2003

Authors

Kenneth A Miles

Articles by these authors

Combined (99m)Tc-methoxyisobutylisonitrile scintigraphy and fine-needle aspiration cytology offers an accurate and potentially cost-effective investigative strategy for the assessment of solitary or dominant thyroid nodules. Eur J Nucl Med Mol Imaging (2013) 2.95

Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice? Insights Imaging (2012) 2.31

Tumor heterogeneity and permeability as measured on the CT component of PET/CT predict survival in patients with non-small cell lung cancer. Clin Cancer Res (2013) 2.08

Non-small cell lung cancer: histopathologic correlates for texture parameters at CT. Radiology (2012) 2.00

Texture analysis of non-small cell lung cancer on unenhanced computed tomography: initial evidence for a relationship with tumour glucose metabolism and stage. Cancer Imaging (2010) 1.98

Assessment of response to tyrosine kinase inhibitors in metastatic renal cell cancer: CT texture as a predictive biomarker. Radiology (2011) 1.84

Cost-effectiveness of 99mTc-sestamibi in predicting response to chemotherapy in patients with lung cancer: systematic review and meta-analysis. J Nucl Med (2009) 1.75

Assessment of primary colorectal cancer heterogeneity by using whole-tumor texture analysis: contrast-enhanced CT texture as a biomarker of 5-year survival. Radiology (2012) 1.46

Multiparametric imaging of tumor response to therapy. Radiology (2010) 1.46

Quantifying tumour heterogeneity with CT. Cancer Imaging (2013) 1.27

Texture analysis in non-contrast enhanced CT: impact of malignancy on texture in apparently disease-free areas of the liver. Eur J Radiol (2008) 1.16

¹⁸F-FDG PET and biomarkers for tumour angiogenesis in early breast cancer. Eur J Nucl Med Mol Imaging (2010) 1.00

In search of biologic correlates for liver texture on portal-phase CT. Acad Radiol (2007) 1.00

Metabolic-flow relationships in primary breast cancer: feasibility of combined PET/dynamic contrast-enhanced CT. Eur J Nucl Med Mol Imaging (2008) 0.95

Hepatic enhancement in colorectal cancer: texture analysis correlates with hepatic hemodynamics and patient survival. Acad Radiol (2007) 0.88

Three-dimensional textural analysis of brain images reveals distributed grey-matter abnormalities in schizophrenia. Eur Radiol (2009) 0.86

Three-dimensional selective-scale texture analysis of computed tomography pulmonary angiograms. Invest Radiol (2008) 0.84

Integrated 18F-fluorodeoxyglucose-positron emission tomography/dynamic contrast-enhanced computed tomography to phenotype non-small cell lung carcinoma. Mol Imaging (2012) 0.82

Cancer imaging: quo vadis? Cancer Imaging (2014) 0.78

Predicting tumour response. Cancer Imaging (2013) 0.77

Concordance of 18F-FDG PET Uptake in Tumor and Normal Tissues on PET/MRI and PET/CT. Clin Nucl Med (2016) 0.77

Renal and hepatic kinetics of Tc-99m-labelled hexakis-methoxy-isobutyl Isonitrile. Drug Metab Lett (2012) 0.76

Incorporating prognostic imaging biomarkers into clinical practice. Cancer Imaging (2013) 0.75

Old tracer for a new purpose: potential role for 99mTc-2-Methoxyisobutylisonitrile (99mTc-MIBI) in renal transplant care. Nucl Med Commun (2014) 0.75